United States Includes India, China and Pakistan in FY-27 List of Major Drug Transit or Illicit Drug-Producing Countries

Key facts

• The United States, in its annual presidential determination submitted to the US Congress on September 15, identified 23 countries, including India, China and Pakistan, as major drug transit or illicit drug-producing countries for fiscal year 2027.
• US President Donald Trump welcomed Prime Minister Narendra Modi and the Indian government's efforts to curb illicit opium poppy cultivation and strengthen supply chain integrity, and looked forward to continued cooperation through the United States-India Drug Policy Framework.
• The determination highlighted China as the world's largest producer of many precursor chemicals used to manufacture fentanyl and methamphetamine, and Trump said the PRC needs to schedule additional chemical precursors requested by the United States.
• Venezuela was given a positive assessment, with Trump determining it should no longer be designated as having failed demonstrably to fulfil its drug control commitments under interim President Delcy Rodriguez.
• Afghanistan, Bolivia, Burma and Colombia were designated as having failed demonstrably over the previous 12 months to fulfil their international counternarcotics obligations.
• Inclusion on the list does not necessarily reflect a government's counterdrug efforts, as countries are identified based on geographic, commercial and economic factors.